From March 1, 2023 to July 27, 2023, the company has repurchased 266,800 shares, representing 0.29% for CAD 0.24 million. With this, the company has completed the repurchase of 296,800 shares, representing 0.33% for CAD 0.26 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 CAD | 0.00% | -4.17% | -16.87% |
1st Jan change | Capi. | |
---|---|---|
-16.87% | 45.29M | |
+10.70% | 216M | |
-8.25% | 190M | |
+23.26% | 160M | |
+300.00% | 121M | |
+25.87% | 114M | |
-42.86% | 96.48M | |
+69.68% | 95.27M | |
-57.11% | 90.59M | |
-15.38% | 73.41M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.